Skip to main content

Advertisement

Log in

Mast cells in rheumatoid arthritis

  • Review
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis (RA) is a chronic disease of joints that is characterized by inflammation, abnormal cellular and humoral immune responses, and synovial hyperplasia. Mast cells (MCs) are involved in several of these inflammatory and immune events. MC-derived mediators induce edema, destroy connective tissue, and are involved in lymphocyte chemotaxis and infiltration and in pathological fibrosis of RA joints. Moreover, MCs are involved in angiogenesis during RA, and their proteolytic activity results in cartilage destruction and bone remodeling. Lastly, MCs could be a target in the treatment of RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Galli SJ (1990) New insight into “the riddle of mast cells”: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 62:5–33

    PubMed  CAS  Google Scholar 

  2. Metcalfe DD, Baram D, Mekori YA (1997) Mast cells. Physiol Rev 77:1033–1079

    PubMed  CAS  Google Scholar 

  3. Irani AM, Schechter NM, Craig SS, De Blois G, Schwartz LB (1986) Two types of human mast cells that have distinct neutral protease composition. Proc Natl Acad Sci USA 83:4464–4468

    Article  PubMed  CAS  Google Scholar 

  4. Irani AM, Schwartz LB (1994) Human mast cell heterogeneity. Allergy Proc 15:303–308

    Article  PubMed  CAS  Google Scholar 

  5. Ishizaka T, Ishizaka K (1984) Activation of mast cells for mediator release through IgE receptor. Prog Allergy 34:188–235

    PubMed  CAS  Google Scholar 

  6. Mekori YA, Metcalfe DD (2000) Mast cells in the innate immunity. Immunol Rev 173:131–140

    Article  PubMed  CAS  Google Scholar 

  7. Benoist C, Mathis D (2002) Mast cells in autoimmune disease. Nature 420:875–878

    Article  PubMed  CAS  Google Scholar 

  8. Maurer M, Theoharides T, Granstein RD, Bischoff SC, Bienenstock J, Henz B, Kovanen P, Piliponsky AM, Kambe N, Vliagoftis H, Levi-Schaffer F, Metz M, Miyachi Y, Befus D, Forsythe P, Kitamura Y, Galli S (2003) What is the physiological function of mast cells? Exp Dermatol 12:886–910

    Article  PubMed  CAS  Google Scholar 

  9. Crivellato E, Finato N, Isola M, Ribatti D, Beltrami CA (2003) Low mast cell density in the human duodenal mucosa from chronic inflammatory duodenal bowel disorders is associated with defective villous architecture. Eur J Clin Investig 33:601–610

    Article  CAS  Google Scholar 

  10. Dvorak AM (1994) Ultrastructural analysis of human basophil and mast cell recovery after secretion. Semin Clin Immunol 8:5–16

    Google Scholar 

  11. Godfrey HP, Ilardi C, Engber W, Graziano FM (1984) Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 27:852–856

    Article  PubMed  CAS  Google Scholar 

  12. Bridges AJ, Malone DG, Jicinsky J, Chen M, Ory P, Engber W, Graziano FM (1991) Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy. Arthritis Rheum 34:1116–1124

    Article  PubMed  CAS  Google Scholar 

  13. Olsson N, Ulfgren AK, Nilsson G (2001) Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients. Ann Rheum Dis 60:187–193

    Article  PubMed  CAS  Google Scholar 

  14. Gotis-Graham I, Smith M, Parker A, McNeil HP (1998) Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann Rheum Dis 57:664–671

    Article  PubMed  CAS  Google Scholar 

  15. Castells MC, Friend DS, Bunnell CA, Hu X, Kraus M, Osteen RT, Austen KF (1996) The presence of membrane-bound stem cell factor on highly immature nonmetachromatic mast cells in the peripheral blood of a patient with aggressive systemic mastocytosis. J Allergy Clin Immunol 98:831–840

    Article  PubMed  CAS  Google Scholar 

  16. Schwartz LB (1994) Mast cells: function and contents. Curr Opin Immunol 6:91–97

    Article  PubMed  CAS  Google Scholar 

  17. Malone DH, Irani AM, Schwartz LB, Barrett KE, Metcalfe DD (1986) Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritis. Arthritis Rheum 29:956–963

    Article  PubMed  CAS  Google Scholar 

  18. Gruber BL, Marchese MJ, Kew RR (1994) Transforming growth factorβ1 mediates mast cell chemotaxis. J Immunol 152:5860–5867

    PubMed  CAS  Google Scholar 

  19. Hartmann K, Henz BM, Krüger-Krasagakes S, Kohl J, Burger R, Guhl S, Haase I, Lippert U, Zuberbier T (1997) C3a and C5a stimulate chemotaxis of human mast cells. Blood 89:2863–2870

    PubMed  CAS  Google Scholar 

  20. Olsson N, Siegbahn A, Nilsson G (1999) Serum amyloid A induces mast cell chemotaxis of human mast cells by activating a pertussis toxin-sensitive signal transduction pathway. Biochem Biophys Res Commun 254:143–146

    Article  PubMed  CAS  Google Scholar 

  21. Nilsson G, Metcalfe DD, Taub DD (2000) Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. Immunology 99:314–319

    Article  PubMed  CAS  Google Scholar 

  22. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB (2002) Mast cell: a cellular link between autoantibodies and inflammatory arthritis. Science 297:1689–1692

    Article  PubMed  CAS  Google Scholar 

  23. Huang M, Berry J, Kandere K, Lytinas M, Karalis K, Theoharides TC (2002) Mast cell deficient W/W(v) mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int J Immunopathol Pharmacol 15:249–254

    PubMed  CAS  Google Scholar 

  24. Mattheos S, Christodoulou S, Kempuraj D, Kempuraj B, Karalis K, Theoharides TC (2003) Mast cells and corticotropin-releasing hormone (CRH) are required for experimental inflammatory arthritis. FASEB J 17:C44

    Google Scholar 

  25. Blue ML, Conrad P, Webb DL, Sarr T, Macaro M (1993) Interacting monocytes and synoviocytes induce adhesion molecules by a cytokine-regulated process, Lymphokine Cytokine Res 12:213–218

    PubMed  CAS  Google Scholar 

  26. Matsushima K, Oppenheim JJ (1989) Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1:2–13

    Article  PubMed  CAS  Google Scholar 

  27. Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades K, Blades S, Mapp PI, Morris CJ, Blake DR, Kaltschmidt C, Baeuerle PA (1996) Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue. Arthritis Rheum 39:583–591

    Article  PubMed  CAS  Google Scholar 

  28. Yoffe JR, Taylor DJ, Wooley DE (1984) Mast cell products stimulate collagenase and prostaglandin E production by cultures of adherent rheumatoid synovial cells. Biochem Biophys Res Commun 122:270–276

    Article  PubMed  CAS  Google Scholar 

  29. Yoffe JR, Taylor DJ, Woolley DE (1985) Mast cell products and heparin stimulate the production of mononuclear-cell factor by cultured human monocyte-macrophages. Biochem J 230:83–88

    PubMed  CAS  Google Scholar 

  30. Ruschpler P, Lorenz P, Eichler W, Koczan D, Hanel C, Scholz R, Melzer C, Thiesen HJ, Stiehl P (2003) High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther 5:R241–R252

    Article  PubMed  CAS  Google Scholar 

  31. Noli C, Miolo A (2001) The mast cells in wound healing. Vet Dermatol 12:303–313

    Article  PubMed  CAS  Google Scholar 

  32. Kiener HP, Hofbauer R, Tohidast-Akrad M, Walchshofer S, Redlich K, Bitzan P, Kapiotis S, Steiner G, Smolen JS, Valent P (2000) Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis. Arthritis Rheum 43:164–174

    Google Scholar 

  33. Stevens RL, Somerville LL, Sewell D, Swafford JR, Caulfield JP, Levi-Schaffer F, Hubbard JR, Dayton ET (1992) Serosal mast cells maintain their viability and promote the metabolism of cartilage proteoglycans when cocultured with chondrocytes. Arthritis Rheum 35:325–335

    Article  PubMed  CAS  Google Scholar 

  34. Chowdhury MH, Hamada C, Dempster DW (1992) Effects of heparin on osteoclast activity. J Bone Miner Res 7:771–777

    Article  PubMed  CAS  Google Scholar 

  35. Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D (2006) Angiogenesis in rheumatoid arthritis. Histol Histopathol 21:557–566

    PubMed  CAS  Google Scholar 

  36. Hiromatsu Y, Toda S (2003) Mast Cells and angiogenesis. Microsc Res Tech 60:64–69

    Article  PubMed  Google Scholar 

  37. Nagashima M, Yoshino S, Ishiwata T, Asano G (1995) Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 22:1624–1630

    PubMed  CAS  Google Scholar 

  38. Yamada T, Sawatsubashi M, Yakushiji H, Itoh Y, Edakuni G, Mori M, Robert L, Miyazaki K (1998) Localization of vascular endothelial growth factor in synovial membrane mast cells: examination with “multi-labelling subtraction immunostaining”. Virchows Arch 433:567–570

    Article  PubMed  CAS  Google Scholar 

  39. Tetlow LC, Wooley DE (1995) Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 54:896–903

    Article  PubMed  CAS  Google Scholar 

  40. Kakizoe E, Li SH, Kobayashi Y, Nishikori N, Dekio S, Okunishi H (1999) Increases in mast cells and chymase in fibroproliferative paws of collagen-induced arthritic mice. Inflamm Res 48:318–324

    Article  PubMed  CAS  Google Scholar 

  41. Lees M, Taylor DJ, Woolley DE (1994) Mast cell proteinases activate precursor forms of collagenase and stromelysin but not of gelatinases A and B. Eur J Biochem 223:171–177

    Article  PubMed  CAS  Google Scholar 

  42. Suzuki K, Lees M, Newlands GFJ, Nagase H, Woolley DE (1995) Activation of precursors for matrix metalloproteinases 1 (collagenase) and 3 (stromelysin) by rat mast cell proteinases I and II. Biochem J 305:301–306

    PubMed  CAS  Google Scholar 

  43. Bonassar LJ, Frank EH, Murray JC, Paguio CG, Moore VL, Lark MW, Sandy JD, Wu JJ, Evre DR, Grodzinsky AJ (1995) Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum 38:173–183

    Article  PubMed  CAS  Google Scholar 

  44. He S, Gaca MDA, Walls AF (2001) The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors. Eur J Pharmacol 412:223–229

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, National and Regional Funds) Milan, Ministry for Education, the Universities and Research (FIRB 2001 and PRIN 2005), Rome, and the Fondazione Italiana per la Lotta al Neuroblastoma, Genoa, Italy.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Domenico Ribatti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maruotti, N., Crivellato, E., Cantatore, F.P. et al. Mast cells in rheumatoid arthritis. Clin Rheumatol 26, 1–4 (2007). https://doi.org/10.1007/s10067-006-0305-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0305-3

Keywords

Navigation